Day One Biopharmaceuticals Inc (DAWN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,256 | -42,393 | -142,181 | -102,072 | -64,277 |
| Depreciation Amortization | 181 | 89 | 531 | 351 | 186 |
| Accounts payable and accrued liabilities | 4,305 | 4,379 | -1,484 | 2,229 | -1,305 |
| Other Working Capital | 6,592 | 7,471 | 6,564 | 7,779 | 908 |
| Other Operating Activity | 8,761 | 4,469 | 26,696 | 17,149 | 13,138 |
| Operating Cash Flow | $-68,417 | $-25,985 | $-109,874 | $-74,564 | $-51,350 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 9,256 | -11,167 | -255,048 | -252,838 | -5,990 |
| PPE Investments | -175 | -26 | -26 | -26 | N/A |
| Other Investing Activity | 0 | 0 | 0 | 0 | -22 |
| Investing Cash Flow | $9,081 | $-11,193 | $-255,074 | $-252,864 | $-6,012 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 162,632 | 1,184 | 165,259 | 163,663 | 161,610 |
| Other Financing Activity | 653 | 0 | 642 | 320 | 320 |
| Financing Cash Flow | $163,285 | $1,184 | $165,901 | $163,983 | $161,930 |
| Beginning Cash Position | 85,262 | 85,262 | 284,309 | 284,309 | 284,309 |
| End Cash Position | 189,211 | 49,268 | 85,262 | 120,864 | 388,877 |
| Net Cash Flow | $103,949 | $-35,994 | $-199,047 | $-163,445 | $104,568 |
| Free Cash Flow | |||||
| Operating Cash Flow | -68,417 | -25,985 | -109,874 | -74,564 | -51,350 |
| Capital Expenditure | -175 | -26 | -26 | -26 | N/A |
| Free Cash Flow | -68,592 | -26,011 | -109,900 | -74,590 | -51,350 |